SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001517126-14-000175
Filing Date
2014-06-10
Accepted
2014-06-10 16:28:27
Documents
1
Period of Report
2013-06-27
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

Document Format Files

Seq Description Document Type Size
1 FORM 8-K form8k.htm 8-K 29620
  Complete submission text file 0001517126-14-000175.txt   31284
Mailing Address 12655 N. CENTRAL EXPRESSWAY SUITE 1000 DALLAS TX 75243
Business Address 12655 N. CENTRAL EXPRESSWAY SUITE 1000 DALLAS TX 75243 972-386-7350
Endocan Corporation. (Filer) CIK: 0000054424 (see all company filings)

IRS No.: 900156146 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 002-41703 | Film No.: 14902377
SIC: 4813 Telephone Communications (No Radiotelephone)